163 related articles for article (PubMed ID: 20706736)
1. Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).
Le Sueur C; Bour S; Schaper R
Parasitol Res; 2010 Nov; 107(6):1463-9. PubMed ID: 20706736
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
Segev G; Rojas A; Lavy E; Yaffe M; Aroch I; Baneth G
Parasit Vectors; 2018 Mar; 11(1):127. PubMed ID: 29506575
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of a topically applied imidacloprid 10 % / moxidectin 2.5 % formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi worms in experimentally infected dogs.
Austin CM; Kok DJ; Crafford D; Schaper R
Parasitol Res; 2013 Aug; 112 Suppl 1():91-108. PubMed ID: 23779222
[TBL] [Abstract][Full Text] [Related]
4. The use of milbemycin oxime in a prophylactic anthelmintic programme to protect puppies, raised in an endemic area, against infection with Spirocerca lupi.
Kok DJ; Williams EJ; Schenker R; Archer NJ; Horak IG
Vet Parasitol; 2010 Dec; 174(3-4):277-84. PubMed ID: 20869809
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.
Lechat C; Siméon N; Pennant O; Desquilbet L; Chahory S; Le Sueur C; Guillot J
Parasit Vectors; 2015 Feb; 8():93. PubMed ID: 25884443
[TBL] [Abstract][Full Text] [Related]
6. Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis.
Rojas A; Segev G; Markovics A; Aroch I; Baneth G
Parasit Vectors; 2017 Sep; 10(1):435. PubMed ID: 28927435
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Beugnet F; Crafford D; de Vos C; Kok D; Larsen D; Fourie J
Vet Parasitol; 2016 Aug; 226():150-61. PubMed ID: 27514901
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
[TBL] [Abstract][Full Text] [Related]
9. Spirocerca lupi in dogs: prophylactic effect of doramectin.
Lavy E; Harrus S; Mazaki-Tovi M; Bark H; Markovics A; Hagag A; Aizenberg I; Aroch I
Res Vet Sci; 2003 Dec; 75(3):217-22. PubMed ID: 13129670
[TBL] [Abstract][Full Text] [Related]
10. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
Bianciardi P; Otranto D
Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
[TBL] [Abstract][Full Text] [Related]
11. Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
Traversa D; Mazzi A; Di Cesare A; Famigli Bergamini P; Fracassi F; Fanini G; Aste G; Pampurini F; Boari A
Parasitol Res; 2013 Nov; 112(11):3753-6. PubMed ID: 23925446
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of doramectin for the treatment of experimental canine spirocercosis.
Lavy E; Aroch I; Bark H; Markovics A; Aizenberg I; Mazaki-Tovi M; Hagag A; Harrus S
Vet Parasitol; 2002 Oct; 109(1-2):65-73. PubMed ID: 12383626
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of milbemycin oxime against pre-adult Spirocerca lupi in experimentally infected dogs.
Kok DJ; Schenker R; Archer NJ; Horak IG; Swart P
Vet Parasitol; 2011 Apr; 177(1-2):111-8. PubMed ID: 21168275
[TBL] [Abstract][Full Text] [Related]
15. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
Taweethavonsawat P; Chungpivat S; Satranarakun P; Traub RJ; Schaper R
Parasitol Res; 2010 May; 106(6):1499-502. PubMed ID: 20349196
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
17. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
Arther RG; Bowman DD; Slone RL; Travis LE
Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
[TBL] [Abstract][Full Text] [Related]
20. Canine spirocercosis.
Mylonakis ME; Rallis T; Koutinas AF
Compend Contin Educ Vet; 2008 Feb; 30(2):111-6. PubMed ID: 18368693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
